Home » Topics » BioWorld Science

BioWorld Science
RSS

Dual MetAP 2/DPP-IV inhibitors identified at Lilly

June 22, 2018

Bristol-Myers Squibb describes glycogen synthase kinase 3 inhibitors

June 22, 2018

New dUTPase inhibitors synthesized at CV6 Therapeutics

June 22, 2018

MaaT Pharma enters agreement for GvHD microbiome therapy

June 22, 2018

Researchers present primary efficacy data on PRO-140 from CD02 study

June 22, 2018

HTX-011 receives breakthrough therapy designation and reaches primary endpoint in phase IIb studies

June 22, 2018

First-in-human data presented for novel monoclonal anti-IL-6R-alpha antibody BCD-089

June 22, 2018

Preliminary data presented from first-in-human phase I trial on MTL-CEBPA

June 22, 2018

Reata initiates first-in-human study with allosteric RORgammat inhibitor RTA-1701

June 22, 2018

PTC Therapeutics presents updated preliminary data from FIREFISH

June 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...